Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Narcolepsy Without Cataplexy”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Testing effectiveness (Phase 2)Study completedNCT01146600
What this trial is testing

Clarithromycin for the Treatment of Hypersomnia

Who this might be right for
HypersomniaIdiopathic HypersomniaNarcolepsy
Lynn Marie Trotti 26
Not applicableNo Longer AvailableNCT03433131
What this trial is testing

Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy

Who this might be right for
Narcolepsy Without CataplexyNarcolepsy With Cataplexy
Harmony Biosciences Management, Inc.
Not applicableTemporarily pausedNCT04419792
What this trial is testing

'A Profile of Physical Performance Variables in an Out-patient Adult Population With Narcolepsy'

Who this might be right for
NarcolepsyNarcolepsy 1Narcolepsy Type 1+4 more
University of Dublin, Trinity College 70
Not applicableUnknownNCT03425214
What this trial is testing

Exploration of the Reward System by Functional MRI in Narco-cataplexy Patients With and Without REM Sleep Behavior Disorder

Who this might be right for
NarcolepsyCataplexy
University Hospital, Clermont-Ferrand 66
Testing effectiveness (Phase 2)Ended earlyNCT04096560
What this trial is testing

TAK-994 in Adults With Type 1 and Type 2 Narcolepsy

Who this might be right for
Narcolepsy Type 1 (NT1)Narcolepsy Type 2 (NT2)
Takeda 97
Large-scale testing (Phase 3)Study completedNCT02611687
What this trial is testing

Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label Period

Who this might be right for
Narcolepsy With CataplexyNarcolepsy Without Cataplexy
Bioprojet 110
Early research (Phase 1)Study completedNCT01093508
What this trial is testing

Single-dose Safety Study of APD916 in Healthy Volunteers

Who this might be right for
Narcolepsy With or Without Cataplexy
Arena Pharmaceuticals 72
Testing effectiveness (Phase 2)Study completedNCT04026958
What this trial is testing

Clarithromycin Mechanisms in Hypersomnia Syndromes

Who this might be right for
Narcolepsy Without CataplexyIdiopathic HypersomniaNarcolepsy With Cataplexy
Emory University 83
Not applicableStudy completedNCT04306952
What this trial is testing

Awareness and Self-Compassion Enhancing Narcolepsy Treatment

Who this might be right for
NarcolepsyNarcolepsy Without CataplexyNarcolepsy With Cataplexy
Northwestern University 60
Testing effectiveness (Phase 2)Study completedNCT05687916
What this trial is testing

TAK-861 in Participants With Narcolepsy Type 2

Who this might be right for
Narcolepsy Type 2
Takeda 71
Testing effectiveness (Phase 2)Study completedNCT03772314
What this trial is testing

Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia

Who this might be right for
Idiopathic HypersomniaNarcolepsy Without Cataplexy
Emory University 44
Testing effectiveness (Phase 2)Looking for participantsNCT06952699
What this trial is testing

TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

Who this might be right for
Narcolepsy Type 2
Takeda 88
Testing effectiveness (Phase 2)Study completedNCT05055024
What this trial is testing

An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy

Who this might be right for
Narcolepsy With CataplexyNarcolepsyNarcolepsy Without Cataplexy
NLS Pharmaceutics 52
Testing effectiveness (Phase 2)Study completedNCT02512588
What this trial is testing

Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2

Who this might be right for
Idiopathic HypersomniaNarcolepsy Without Cataplexy
Balance Therapeutics 120
Not applicableLooking for participantsNCT06383806
What this trial is testing

Decreasing Nightmares in Adults With Narcolepsy

Who this might be right for
NarcolepsyNarcolepsy Type 1Narcolepsy With Cataplexy+3 more
University of Utah 80
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Testing effectiveness (Phase 2)Study completedNCT01183312
What this trial is testing

Flumazenil for the Treatment of Primary Hypersomnia

Who this might be right for
HypersomniaPrimary HypersomniaIdiopathic Hypersomnia+1 more
Lynn Marie Trotti 10
Not applicableStudy completedNCT05709873
What this trial is testing

Narcolepsy Nightmare Study

Who this might be right for
NarcolepsyNarcolepsy Type 1Narcolepsy With Cataplexy+2 more
Northwestern University 7
Testing effectiveness (Phase 2)Study completedNCT04072380
What this trial is testing

Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy

Who this might be right for
Narcolepsy
Suven Life Sciences Limited 190